| Biomarker ID | 1207 |
| PMID | 23991666 |
| Year | 2013 |
| Biomarker | Neuropeptideâ€Y (NPY) + Prostate Specific Antigen (PSA) |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Plasma |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs (Normal and BPH patients) |
| Type of Biomarker | Diagnostic |
| Cohort | Plasma from 24 healthy controls, 19 benign prostate hypertrophy patients, and 73 prostate cancer patients was taken |
| Senstivity | 81.5% |
| Specificity | 82.2% |
| AUC | 0.88 |
| Accuracy | NA |
| Level Of Significance | p = 0.0396 |
| Method Used | QUEST-MS (Quick Enrichment of Small Targets for Mass Spectrometry) |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |